更新日 : 2025年05月07日

1. Kuroda S, Funasaki S, Nishizawa H, Schmidt L S, Kurahashi R, Ito T, Arima Y, Tanaka M, Kitada A, James Amy M, Hasumi H, Jikuya R, Makiyama K, Kurotaki D, Minami T, Difilippantonio S, Linehan WM, Oike Y, Sawa T, Tanaka Y, Suda T, Yokokawa R, Nakamura T, Baba M, Kamba T. The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RCC. Neoplasia, 75: 101296, 2026.
2. Tanaka M and Nakamura T. Genetically engineered mouse model in Ewing sarcoma. Methods Mol Biol, . 2nd edition, 2026.
3. Tanaka M* and Nakamura T. Role of the RAB27/SYTL Axis in Tumor Microenvironment Construction. Cancer Sci (review), 116(7):1815-1822, 2025. (*corresponding author)
4. Nakano Y, Tanaka M, Sakamoto T, Hashimoto M, Tobo T, Saito H, Abe T, Ikehara T, Ofuchi T, Kawata K, Masuda T, Ogino T, Uemura M, Eguchi H, Doki Y, Mimori K. Epigenetic Regulation of G6PD Drives Metabolic Reprogramming in Intrahepatic Cholangiocarcinoma. Cancer Sci, 116(12):3352-3366, 2025.
5. Iesato A, Suzuka J, Otsuji K, Osako T, Yamashita N, Inoue Y, Maeda T, Uehiro N, Yoshida K, Takahashi Y, Kumegawa K, Saeki S, Yang L, Tsuchiya A, Sakiyama K, Tanaka M, Sakai T, Ohno S, Noda F, Ueno T, Maruyama R. Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer. Breast Cancer Res, 27(1):109, 2025.
6. Chuaychob S, Lyu R, Tanaka M, Haginiwa A, Kitada A, Nakamura T, Yokokawa R. Mimicking angiogenic microenvironment of alveolar soft-part sarcoma in a microfluidic coculture vasculature chip. Proc Natl Acad Sci USA, 121(13): e2312472121, 2024.
7. Ishihara K, Sakoda R, Mizoguchi M, Fujita M, Moyama C, Okutani Y, Takata K, Tanaka M, Minami T, Sago H, Yamakawa K, Nakamura T, Kawashita E, Akiba S, Nakata S. Suppression of Sleeping Beauty-induced Gliomagenicity in Ts1Cje Mice, a Model of Down Syndrome. Anticancer Res. 44(2):489-495, 2024.
8. Tanaka M*, Homme M, Teramura Y, Kumegawa K, Yamazaki Y, Yamashita K, Osato M, Maruyama R, Nakamura T*. HEY1::NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice. JCI Insight, 8(10):e160279, 2023. (*co-corresponding author)
9. Yamashita K, Baba S, Togashi Y, Dobashi A, Ae K, Matsumoto S, Tanaka M, Nakamura T, Takeuchi K. Clinicopathologic and genetic characterization of angiofibroma of soft tissue: a study of 12 cases including two cases with AHRR::NCOA3 gene fusion. Histopathology, 83(1):57-66, 2023.
10. Tanaka M*, Chuaychob S, Homme M, Yamazaki Y, Lyu R, Yamashita K, Ae K, Matsumoto S, Maruyama R, Qu W, Miyagi Y, Yokokawa R, Nakamura T*. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma. Nat Commun, 14(1):1957, 2023. (†co-corresponding author)
11. Tanaka M and Nakamura T. Targeting epigenetic aberrations of sarcoma in CRISPR era. Genes Chromosomes Cancer, 62(9):510-525, 2023. DOI: 10.1002/gcc.23142
12. Kameda Y, Chuaychob S, Tanaka M, Liu Y, Okada R, Fujimoto K, Nakamura T, Yokokawa R. Three-dimensional tissue model in direct contact with an on-chip vascular bed enabled by removable membranes. Lab Chip, 22(3):641-651, 2022, doi: 10.1039/d1lc00751c
13. Yoshino S, Tanaka M, Sunami Y, Takahara T, Yamazaki Y, Homme M, Niibori-Nambu A, Osato M, Minami T, Ishihara K, Nakamura T. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome. Leukemia, 36(2):558-561, 2021.
14. Tanaka M and Nakamura T. Genetically Engineered Mouse Model in Ewing Sarcoma. Methods Mol Biol, . 2226:183-189, 2021.
15. Tanaka M and Nakamura T. Modeling fusion gene-associated sarcoma: Advantages for understanding sarcoma biology and pathology. Pathol Int. (review), 71:643-654, 2021.
16. Teramura Y, Tanaka M, Yamazaki Y, Yamashita K, Takazawa Y, Ae K, Matsumoto S, Nakayama T, Kaneko T, Musha Y, Nakamura T. Identification of novel fusion genes in bone and soft tissue sarcoma and their implication in the generation of a mouse model. Cancers, 12(9): E2345, 2020.
17. Tanaka M, Homme M, Yamazaki Y, Ae K, Matsumoto S, Subramanian S, Nakamura T. Cooperation between SS18-SSX1 and miR-214 in synovial sarcoma development and progression. Cancers, 12(2), E324, 2020.

2019年以前（抜粋）

1. Teramura Y, Yamazaki Y, Tanaka M, Sugiura Y, Takazawa Y, Takeuchi K, Nakayama T, Kaneko T, Musha Y, Funauchi Y, Ae K, Matsumoto S, Nakamura T. Case of mesenchymal tumor with the PPP6R3-USP6 fusion, possible nodular fasciitis with malignant transformation. Pathol Int, 69(12), 706-709, 2019.
2. Supakul S, Yao K, Ochi H, Shimada T, Hashimoto K, Sunamura S, Mabuchi Y, Tanaka M, Akazawa C, Nakamura T, Okawa A, Takeda S, Sato S. Pericytes as a source of osteogenic cells in bone fracture healing. Int J Mol Sci, 20, 1079, 2019.
3. Namatame N, Tamaki N, Yoshizawa Y, Okamura M, Nishimura Y, Yamazaki K, Tanaka M, Nakamura T, Semba K, Yamori T, Yaguchi SI, Dan S. Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines. Oncotarget, 12;9(80):35141-35161, 2018.
4. Shimizu R, Tanaka M, Tsutsumi S, Abratani H, Yamazaki Y, Homme M, Kitagawa Y Nakamura T. EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma. Cancer Sci, 109(9). 2907-2918, 2018.
5. Tanaka M, Yoshimoto T, Nakamura T. A double-edged sword: The world according to Capicua in cancer. Cancer Sci (review), 108(12), 2319-2325, 2017.
6. Yoshimoto T#, Tanaka M#, Homme M, Yamazaki Y, Takazawa Y, Antonescu C. R and Nakamura T. CIC-DUX4 induces small round cell sarcomas distinct from Ewing sarcoma. Cancer Res, 77(11), 2927-2937, 2017. (#equally contributed)
7. Tanaka M, Homme M, Yamazaki Y, Shimizu R, Takazawa Y, Nakamura T. Modeling alveolar soft part sarcoma unveils novel mechanisms of metastasis. Cancer Res, 77(4) 897-907, 2017.
8. Minas TZ#, Surdez D#, Javaheri T#, Tanaka M#, Howarth M#, Kang HJ#, Han J, Han ZY, Sax B, Kream BE, Hong SH, Celik H, Tirode F, Tuckermann J, Toretsky JA, Kenner L, Kovar H, Lee S, Sweet-Cordero EA, Nakamura T, Moriggl R, Delattre O, Uren A. Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model. Oncotarget, 8(21), 34141-63, 2017. (#equally contributed)
9. Tanaka M, Yamaguchi S, Yamazaki Y, Kinoshita H, Kuwahara K, Nakao K, Jay P, Noda T, Nakamura T. Somatic chromosomal translocation between Ewsr1 and Fli1 loci leads to dilated cardiomyopathy in a mouse model. Scientific Rep, 5, 7826, 2015.
10. Tanaka M, Yamazaki Y, Kanno Y, Igarashi K, Aisaki K, Kanno J, Nakamura T. Ewing’s sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors. J Clin Invest, 124(7), 3061-3074, 2014.